BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cattaneo D, Cossu MV, Rizzardini G. Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV. Expert Opin Drug Metab Toxicol 2019;15:927-35. [PMID: 31668105 DOI: 10.1080/17425255.2019.1685495] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdel-qader DH, Al Meslamani AZ, Albassam A, Al Mazrouei N, El-shara AA, El Sharu H, Ebaed SBM, Ibrahim OM. Assessment of A new Strategy to Prevent Prescribing Errors Involving COVID-19 Patients in Community Pharmacies. Hosp Pharm. [DOI: 10.1177/00185787211073506] [Reference Citation Analysis]
2 Lazniewski M, Dermawan D, Hidayat S, Muchtaridi M, Dawson W, Plewczynski D. Drug repurposing for identification of potential spike inhibitors for SARS-CoV-2 using molecular docking and molecular dynamics simulations. Methods 2022. [DOI: 10.1016/j.ymeth.2022.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
3 Santos GC, Martins LM, Bregadiolli BA, Moreno VF, Silva‐filho LC, Silva BHST. Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications. J Heterocyclic Chem 2021;58:2226-60. [DOI: 10.1002/jhet.4349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Marin RC, Behl T, Negrut N, Bungau S. Management of Antiretroviral Therapy with Boosted Protease Inhibitors-Darunavir/Ritonavir or Darunavir/Cobicistat. Biomedicines 2021;9:313. [PMID: 33803812 DOI: 10.3390/biomedicines9030313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cattaneo D, Formenti T, Gidaro A, Merlo A, Gervasoni C. Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience. Semin Thromb Hemost 2020;46:999-1001. [PMID: 33368115 DOI: 10.1055/s-0040-1718398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Cattaneo D, Pasina L, Maggioni AP, Giacomelli A, Oreni L, Covizzi A, Bradanini L, Schiuma M, Antinori S, Ridolfo A, Gervasoni C. Drug-Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy. Drugs Aging 2020;37:925-33. [PMID: 33150470 DOI: 10.1007/s40266-020-00812-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol 2020;94:3671-722. [PMID: 33111191 DOI: 10.1007/s00204-020-02936-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
8 Elens L, Langman LJ, Hesselink DA, Bergan S, Moes DJAR, Molinaro M, Venkataramanan R, Lemaitre F. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions. Ther Drug Monit. 2020;42:360-368. [PMID: 32304488 DOI: 10.1097/ftd.0000000000000761] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]